Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
Alessio CortelliniMaria G VitaleFederica De GalitiisFrancesca R Di PietroRossana BerardiMariangela TorniaiMichele De TursiAntonino GrassadoniaPietro Di MarinoDaniele SantiniTea ZeppolaCecilia AnesiAlain GelibterMario Alberto OcchipintiAndrea BotticelliPaolo MarchettiFrancesca RastelliFederica PergolesiMarianna TudiniRosa Rita SilvaDomenico MallardoVito VanellaCorrado FicorellaGiampiero PorzioPaolo A AsciertoPublished in: Journal of translational medicine (2019)
Early ir-fatigue seems to be negative prognostic parameter, but to proper weight its role we must to consider the predominant role of performance status, which was related to early ir-fatigue in the study population.